Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 6, September

Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers

Volume:6   Issue: 6
Pp: 455-489
D. N. Waterhouse, K. A. Gelmon, R. Klasa, K. Chi, D. Huntsman, E. Ramsay, E. Wasan, L. Edwards, C. Tucker, J. Zastre, Y. Z. Zhang, D. Yapp, W. Dragowska, S. Dedha and M. B. Bally
DOI: 10.2174/156800906778194586
Published on: 01 March, 2012

Synthetic Glycopeptides from the Mucin Family as Potential Tools in Cancer Immunotherapy

Volume:6   Issue: 6
Pp: 491-517
Torsten Becker, Sebastian Dziadek, Sven Wittrock and Horst Kunz
DOI: 10.2174/156800906778194577
Published on: 01 March, 2012

Protein Tyrosine Phosphatases, New Targets for Cancer Therapy

Volume:6   Issue: 6
Pp: 519-532
David Easty, William Gallagher and D. C. Bennett
DOI: 10.2174/156800906778194603
Published on: 01 March, 2012

Knowledge of Epigenetic Influence for Prostate Cancer Therapy

Volume:6   Issue: 6
Pp: 533-551
Masatoshi Watanabe, Akimitsu Takagi, Takeshi Matsuzaki, Daisuke Kami, Minoru Toyota, Yoshifumi Hirokawa and Taizo Shiraishi
DOI: 10.2174/156800906778194568
Published on: 01 March, 2012

Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS

Volume:6   Issue: 6
Pp: 553-563
Hironori Harada, Yuka Harada and Akiro Kimura
DOI: 10.2174/156800906778194595
Published on: 01 March, 2012